Cardiac device therapy has significantly evolved since the introduction of the first implantable pacemaker and the subsequent ...

Axillary vein access has emerged as a safe and efficient alternative for cardiac device implantation. By utilising the anatomical course of the axillary vein, clinicians can facilitate the insertion ...

HOUSTON & BELFAST, Northern Ireland--(BUSINESS WIRE)--B-Secur, an innovator in advanced biosensing technology, and Galen Data, a leading software platform for medical device-to-cloud connectivity and ...

Philadelphia, February 20, 2025 – Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of complication due to its invasive nature.

Future Cardia, a medical device company, announced an expanded collaboration with remote cardiac monitoring company, Artella Solutions. Future Cardia is developing an implantable cardiac monitoring ...

A Florida hospital has developed a system for wireless real-time monitoring and reprogramming of cardiac devices, including pacemakers and defibrillators, using an iPad. A doctor can suggest changes ...

Birmingham-based Fallouh Healthcare has been awarded a grant of £305,050 from Innovate UK as part of the Eureka Eurostar programme to finalise a prototype of PerDeCT™, working alongside their Austrian ...

Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter ...

Endomyocardial biopsy (EMB) is a valuable method for diagnosing a range of cardiac conditions, but there is a risk of ...

"This partnership underscores the need for robust cardiac monitoring solutions in a rapidly evolving healthcare landscape," said Dr. Waqaas Al-Siddiq, founder and CEO of Biotricity. "By working with B ...

National registry study ranks strategies by initial, final success ...